Get the Stockscreener App
380.92
0.40%
-1.54
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $380.92, with a volume of 758.78K.
It is down -0.40% in the last 24 hours and up +4.95% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$382.46
Open:
$382.2
24h Volume:
758.78K
Relative Volume:
0.49
Market Cap:
$144.54B
Revenue:
$23.22B
Net Income/Loss:
$2.86B
P/E Ratio:
51.48
EPS:
7.4
Net Cash Flow:
$3.58B
1W Performance:
+0.71%
1M Performance:
+4.95%
6M Performance:
+1.32%
1Y Performance:
+15.13%
1-Day Range:
$380.28
$384.55
1-Week Range:
$373.06
$388.32
52-Week Range:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold) (NYSE:SYK) - Seeking Alpha
Why Stryker Corporation (SYK) Is Among the Best Medical Device Stocks to Buy Now - Insider Monkey
Stryker Director Makes a Multi-Million Dollar Stock Move! - TipRanks
Stryker declares an $0.84 per share quarterly dividend - Ortho Spine News
Stryker (SYK) Announces Steady Dividend with Promising Growth Forecast - GuruFocus
Stryker raises dividend to $0.84 per share for Q2 - Investing.com
Stryker Declares An $0.84 Per Share Quarterly Dividend - Barchart.com
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today - Benzinga
Stryker (SYK) Receives Price Target Boost Following Strong Quart - GuruFocus
Stryker, Lockheed Martin, Rockwell Automation And More On CNBC's 'Final Trades' - Benzinga
Reflecting On Medical Devices & SuppliesDiversified Stocks’ Q1 Earnings: Stryker (NYSE:SYK) - Yahoo Finance
Stryker (SYK) Price Target Raised by Truist Securities | SYK Sto - GuruFocus
Stryker (SYK) Price Target Raised by Truist Securities | SYK Stock News - GuruFocus
UBS lifts Stryker stock price target to $421 from $405 - Investing.com
Stryker's (SYK) Price Target Raised by Truist Amid Strong Growth - GuruFocus
Demystifying Stryker: Insights From 5 Analyst Reviews - Benzinga
Stryker's (SYK) Price Target Raised by Truist Amid Strong Growth | SYK Stock News - GuruFocus
Stryker (SYK) Receives Price Target Boost Following Strong Quarterly Results | SYK Stock News - GuruFocus
Decoding Stryker Corp (SYK): A Strategic SWOT Insight - GuruFocus
Stryker Corp’s Earnings Call Highlights Robust Growth - TipRanks
Stryker (SYK) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Stryker price target raised to $456 from $405 at Roth Capital - TipRanks
Stryker says bribery probe dropped by US Justice Department - MLex
Stryker (SYK) Lands a Higher Price Target from Roth MKM | SYK Stock News - GuruFocus
Stryker (SYK) Rating Maintained, Price Target Lowered by Evercore ISI Group | SYK Stock News - GuruFocus
Stryker (SYK): Roth Capital Boosts Price Target Amid Strong Q1 P - GuruFocus
Medical Equipment Makers Stryker, Becton Eye Price Hikes to Offset Tariffs - Bloomberg
Stryker (SYK): Roth Capital Boosts Price Target Amid Strong Q1 Performance | SYK Stock News - GuruFocus
Stryker raises forecast on strong sales despite $200M tariff hit - Crain's Grand Rapids Business
Stryker Corporation (SYK) Sees Strong Q1 2025 Growth Amid Strate - GuruFocus
Stryker Corporation (NYSE:SYK) Q1 2025 Earnings Call Transcript - Insider Monkey
Stryker stock target cut to $390 by Evercore ISI - Investing.com
Stryker beats quarterly estimates of string medical device demand - Reuters
Stryker Corp Reports Strong Q1 2024 Earnings Growth - TipRanks
Stryker Corp (SYK) Q1 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ... - Yahoo Finance
Stryker Corp (SYK) Q1 2025 Earnings: Revenue Surpasses Estimates at $5.9 Billion, EPS Falls Short at $1.69 - GuruFocus
Stryker Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Stryker: Q1 Earnings Snapshot - MySA
Stryker Corporation (SYK) Sees Strong Q1 2025 Growth Amid Strategic Shifts - GuruFocus
Stryker's Profits Outshine Forecasts Thanks To Device Demand - Finimize
Earnings call transcript: Stryker Q1 2025 beats EPS forecasts, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Stryker Q1 2025 beats EPS forecasts, stock dips - Investing.com
Stryker reports first quarter 2025 operating results - ADVFN
Stryker (SYK) Surpasses Q1 Earnings and Revenue Estimates - Yahoo
Stryker earnings beat by $0.13, revenue topped estimates - Investing.com
SYK Reports Strong Q1 Revenue, Beating Expectations | SYK Stock News - GuruFocus
Stryker beats Q1 estimates, raises 2025 organic sales outlook By Investing.com - Investing.com India
Stryker beats Q1 estimates, raises 2025 organic sales outlook - Investing.com
Stryker Corp. Q1 Profit Decreases, But Beats Estimates - Nasdaq
Here's How Much $1000 Invested In Stryker 10 Years Ago Would Be Worth Today - Benzinga
Global Spinal Stenosis Devices Market to reach USD 4,131.08 million at a CAGR of 4.83% by 2030, Evaluates DelveInsight | Spinal Simplicity, Boston Scientific Corporation, Medtronic, Stryker, Surgalig - Barchart.com
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):